A pharmaceutical company called Medytox Inc. (Medytox) creates, produces, and sells biopharmaceutical goods. Hyaluronic acid filler, botulinum toxin, and medical devices are among the company's goods. Neuronox, Meditoxin, Botulift, Cunox, Siax, Acebloc, Innotox, and Coretox are its botulinum toxin type A products. The hyaluronic acid filler in Medytox gives the neuramis a boost. Neurakin cream is also sold by the business. The business offers comfortdual, a high-frequency current-powered medical device for tissue coagulation. In Taiwan, China, Hong Kong, Japan, and Thailand, it operates manufacturing facilities, R&D facilities, and joint venture firms. South Korea's Chungcheongbuk-do province, Cheongju-si, is home to Medytox's headquarters. Since 2009, Medytox has held close to 40% of the market in Korea, and with the addition of additional indications, this proportion is predicted to rise even more. With a significant market share in the worldwide botulinum industry, Medytox is astounding the globe. We want to introduce the presently being developed new kind of botulinum toxin products along with exceeding 10% of the market share in the worldwide market with the aim of breaking into the US and European markets. By setting ambitious goals for the worldwide market, Medytox will become the biopharmaceutical sector's leader in the next years.